vs
Biofrontera Inc.（BFRI）与NexPoint Real Estate Finance, Inc.（NREF）财务数据对比。点击上方公司名可切换其他公司
Biofrontera Inc.的季度营收约是NexPoint Real Estate Finance, Inc.的1.5倍（$17.1M vs $11.1M），NexPoint Real Estate Finance, Inc.净利率更高（216.6% vs 33.0%，领先183.6%），Biofrontera Inc.同比增速更快（36.2% vs -48.8%）
Biofrontera Inc.是一家专注于皮肤病治疗领域的特种生物制药企业，主要研发和商业化处方类皮肤科药物，核心产品线针对光化性角化病等常见皮肤病症，主要市场覆盖美国及欧盟地区，服务皮肤科医护人员与患者。
NexPoint Real Estate Finance, Inc.是一家总部位于美国的商业地产金融企业，主要为多户住宅、写字楼、工业及酒店物业提供结构化融资方案，运营并管理抵押贷款及其他地产相关投资组合，为利益相关方提供经风险调整的稳定回报。
BFRI vs NREF — 直观对比
营收规模更大
BFRI
是对方的1.5倍
$11.1M
营收增速更快
BFRI
高出85.0%
-48.8%
净利率更高
NREF
高出183.6%
33.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $17.1M | $11.1M |
| 净利润 | $5.6M | $24.0M |
| 毛利率 | — | — |
| 营业利润率 | 26.6% | — |
| 净利率 | 33.0% | 216.6% |
| 营收同比 | 36.2% | -48.8% |
| 净利润同比 | 504.0% | 58.7% |
| 每股收益（稀释后） | $0.62 | $0.47 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BFRINREF
| Q4 25 | $17.1M | $11.1M | ||
| Q3 25 | $7.0M | $12.5M | ||
| Q2 25 | $9.0M | $12.1M | ||
| Q1 25 | $8.6M | $11.5M | ||
| Q4 24 | $12.6M | $21.7M | ||
| Q3 24 | $9.0M | $12.5M | ||
| Q2 24 | $7.8M | $6.7M | ||
| Q1 24 | $7.9M | $-12.8M |
净利润BFRINREF
| Q4 25 | $5.6M | $24.0M | ||
| Q3 25 | $-6.6M | $50.9M | ||
| Q2 25 | $-5.3M | $22.3M | ||
| Q1 25 | $-4.2M | $26.0M | ||
| Q4 24 | $-1.4M | $15.2M | ||
| Q3 24 | $-5.7M | $23.3M | ||
| Q2 24 | $-257.0K | $12.1M | ||
| Q1 24 | $-10.4M | $-14.6M |
营业利润率BFRINREF
| Q4 25 | 26.6% | — | ||
| Q3 25 | -89.8% | — | ||
| Q2 25 | -56.2% | — | ||
| Q1 25 | -52.9% | — | ||
| Q4 24 | -13.6% | — | ||
| Q3 24 | -55.0% | — | ||
| Q2 24 | -64.7% | — | ||
| Q1 24 | -69.1% | — |
净利率BFRINREF
| Q4 25 | 33.0% | 216.6% | ||
| Q3 25 | -95.1% | 407.0% | ||
| Q2 25 | -59.0% | 184.5% | ||
| Q1 25 | -48.9% | 225.6% | ||
| Q4 24 | -11.1% | 69.9% | ||
| Q3 24 | -62.9% | 186.4% | ||
| Q2 24 | -3.3% | 179.7% | ||
| Q1 24 | -131.9% | 114.3% |
每股收益（稀释后）BFRINREF
| Q4 25 | $0.62 | $0.47 | ||
| Q3 25 | $-0.62 | $1.14 | ||
| Q2 25 | $-0.57 | $0.54 | ||
| Q1 25 | $-0.47 | $0.70 | ||
| Q4 24 | $0.69 | $0.71 | ||
| Q3 24 | $-0.98 | $0.74 | ||
| Q2 24 | $-0.05 | $0.40 | ||
| Q1 24 | $-2.88 | $-0.83 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $6.4M | $31.1M |
| 总债务越低越好 | — | $771.2M |
| 股东权益账面价值 | $10.5M | $388.0M |
| 总资产 | $28.6M | $5.3B |
| 负债/权益比越低杠杆越低 | — | 1.99× |
8季度趋势，按日历期对齐
现金及短期投资BFRINREF
| Q4 25 | $6.4M | $31.1M | ||
| Q3 25 | $3.4M | $17.9M | ||
| Q2 25 | $7.2M | $9.1M | ||
| Q1 25 | $1.8M | $19.2M | ||
| Q4 24 | $5.9M | $3.9M | ||
| Q3 24 | $2.9M | $34.7M | ||
| Q2 24 | $4.4M | $4.3M | ||
| Q1 24 | $3.8M | $13.5M |
总债务BFRINREF
| Q4 25 | — | $771.2M | ||
| Q3 25 | — | $720.9M | ||
| Q2 25 | — | $815.6M | ||
| Q1 25 | — | $831.5M | ||
| Q4 24 | — | $799.3M | ||
| Q3 24 | — | $815.5M | ||
| Q2 24 | — | $861.0M | ||
| Q1 24 | — | $843.3M |
股东权益BFRINREF
| Q4 25 | $10.5M | $388.0M | ||
| Q3 25 | $-2.6M | $375.4M | ||
| Q2 25 | $-4.7M | $348.2M | ||
| Q1 25 | $500.0K | $343.7M | ||
| Q4 24 | $4.4M | $336.5M | ||
| Q3 24 | $5.5M | $335.8M | ||
| Q2 24 | $10.9M | $327.5M | ||
| Q1 24 | $-5.4M | $327.1M |
总资产BFRINREF
| Q4 25 | $28.6M | $5.3B | ||
| Q3 25 | $15.4M | $5.3B | ||
| Q2 25 | $20.1M | $5.4B | ||
| Q1 25 | $16.6M | $5.4B | ||
| Q4 24 | $22.1M | $5.4B | ||
| Q3 24 | $18.5M | $5.7B | ||
| Q2 24 | $21.6M | $6.6B | ||
| Q1 24 | $24.6M | $7.1B |
负债/权益比BFRINREF
| Q4 25 | — | 1.99× | ||
| Q3 25 | — | 1.92× | ||
| Q2 25 | — | 2.34× | ||
| Q1 25 | — | 2.42× | ||
| Q4 24 | — | 2.38× | ||
| Q3 24 | — | 2.43× | ||
| Q2 24 | — | 2.63× | ||
| Q1 24 | — | 2.58× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.4M | $-4.5M |
| 自由现金流经营现金流 - 资本支出 | $-2.4M | — |
| 自由现金流率自由现金流/营收 | -13.9% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | -0.42× | -0.19× |
| 过去12个月自由现金流最近4个季度 | $-13.4M | — |
8季度趋势，按日历期对齐
经营现金流BFRINREF
| Q4 25 | $-2.4M | $-4.5M | ||
| Q3 25 | $-3.8M | $8.1M | ||
| Q2 25 | $-3.0M | $3.3M | ||
| Q1 25 | $-4.1M | $16.0M | ||
| Q4 24 | $-1.0M | $4.4M | ||
| Q3 24 | $-1.2M | $14.7M | ||
| Q2 24 | $-4.7M | $-7.5M | ||
| Q1 24 | $-3.3M | $17.7M |
自由现金流BFRINREF
| Q4 25 | $-2.4M | — | ||
| Q3 25 | $-3.8M | — | ||
| Q2 25 | $-3.0M | — | ||
| Q1 25 | $-4.1M | — | ||
| Q4 24 | $-1.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-4.8M | — | ||
| Q1 24 | $-3.4M | — |
自由现金流率BFRINREF
| Q4 25 | -13.9% | — | ||
| Q3 25 | -54.7% | — | ||
| Q2 25 | -33.7% | — | ||
| Q1 25 | -48.0% | — | ||
| Q4 24 | -8.1% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -60.8% | — | ||
| Q1 24 | -42.7% | — |
资本支出强度BFRINREF
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.6% | — | ||
| Q1 24 | 0.7% | — |
现金转化率BFRINREF
| Q4 25 | -0.42× | -0.19× | ||
| Q3 25 | — | 0.16× | ||
| Q2 25 | — | 0.15× | ||
| Q1 25 | — | 0.62× | ||
| Q4 24 | — | 0.29× | ||
| Q3 24 | — | 0.63× | ||
| Q2 24 | — | -0.62× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
